Incepta introduces anti-diabetic injection ‘Orsema’

Incepta Pharmaceuticals Limited launched an anti-diabetic medicine injection named "Orsema".

The injectable semaglutide medicine introduced marking this year's ‘World Diabetes Day’ at BIRDEM on Sunday, said a media statement.

According to the statement, a weekly dose of ‘Orsema’ will manage blood glucose levels among diabetic patients. It will remove the hassle of daily medicine taking of diabetes patients.

The injection will be available in the market in two doses— 0.25mg priced at Tk 350 and 0.50mg priced at Tk 600.

Incepta Pharmaceuticals is working always to control diabetes in the country, added the statement.